Download PDF

Other users also viewed these articles

Clinical and molecular implications of antipsychotics in MASLD Celina Gonzalez; Misael Uribe; Norberto C. Chavez-Tapia;
10.1016/j.aohep.2025.102158
Accurate prediction of all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease using electronic health records Ignat Drozdov; Benjamin Szubert; Ian A. Rowe; Timothy J. Kendall; Jonathan A. Fallowfield;
10.1016/j.aohep.2024.101528
A data-driven approach to decode metabolic dysfunction-associated steatotic liver disease Maria Jimenez Ramos; Timothy J. Kendall; Ignat Drozdov; Jonathan A. Fallowfield;
Ann Hepatol. 2024;29: